Drug Profile
Research programme: small molecule therapeutics - Cardax Pharmaceuticals
Alternative Names: CDX-303; CDX-505; OcuXan; Prostatix; Zeaxanthin estersLatest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator Cardax Pharmaceuticals
- Class Anti-inflammatories; Antineoplastics; Hepatoprotectants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Liver disorders; Prostate cancer